DK0925504T3 - Fremgangsmåde til påvisning og/eller kvantitativ bestemmelse af en gliotoksisk faktor - Google Patents

Fremgangsmåde til påvisning og/eller kvantitativ bestemmelse af en gliotoksisk faktor

Info

Publication number
DK0925504T3
DK0925504T3 DK97919095T DK97919095T DK0925504T3 DK 0925504 T3 DK0925504 T3 DK 0925504T3 DK 97919095 T DK97919095 T DK 97919095T DK 97919095 T DK97919095 T DK 97919095T DK 0925504 T3 DK0925504 T3 DK 0925504T3
Authority
DK
Denmark
Prior art keywords
factor
cells
initial
sample
adherent
Prior art date
Application number
DK97919095T
Other languages
English (en)
Inventor
Carine Malcus-Vocanson
Herve Perron
Bernard Mandrand
Original Assignee
Bio Merieux
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Merieux filed Critical Bio Merieux
Application granted granted Critical
Publication of DK0925504T3 publication Critical patent/DK0925504T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
DK97919095T 1996-09-12 1997-09-12 Fremgangsmåde til påvisning og/eller kvantitativ bestemmelse af en gliotoksisk faktor DK0925504T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9611347 1996-09-12
PCT/FR1997/001620 WO1998011439A1 (fr) 1996-09-12 1997-09-12 Procede de detection et/ou de quantification d'un facteur gliotoxique

Publications (1)

Publication Number Publication Date
DK0925504T3 true DK0925504T3 (da) 2001-07-23

Family

ID=9495830

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97919095T DK0925504T3 (da) 1996-09-12 1997-09-12 Fremgangsmåde til påvisning og/eller kvantitativ bestemmelse af en gliotoksisk faktor

Country Status (9)

Country Link
US (1) US6270953B1 (da)
EP (1) EP0925504B1 (da)
JP (1) JP2001504686A (da)
AT (1) ATE199782T1 (da)
CA (1) CA2266124A1 (da)
DE (1) DE69704279T2 (da)
DK (1) DK0925504T3 (da)
ES (1) ES2157569T3 (da)
WO (1) WO1998011439A1 (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2797402B1 (fr) * 1999-07-15 2004-03-12 Biomerieux Stelhys Utilisation d'un polypeptide pour detecter, prevenir ou traiter un etat pathologique associe a une maladie degenerative, neurologique ou autoimmune
DE10053521B4 (de) * 2000-10-27 2004-07-08 november Aktiengesellschaft Gesellschaft für Molekulare Medizin Verfahren zum Nachweis apoptotischer und nekrotischer Zellen
US20120077206A1 (en) 2003-07-12 2012-03-29 Accelr8 Technology Corporation Rapid Microbial Detection and Antimicrobial Susceptibility Testing
US7341841B2 (en) 2003-07-12 2008-03-11 Accelr8 Technology Corporation Rapid microbial detection and antimicrobial susceptibility testing
WO2005027714A2 (en) * 2003-07-12 2005-03-31 Accelr8 Technology Corporation Sensitive and rapid biodetection
US10254204B2 (en) 2011-03-07 2019-04-09 Accelerate Diagnostics, Inc. Membrane-assisted purification
EP2683831B1 (en) 2011-03-07 2015-09-23 Accelerate Diagnostics, Inc. Rapid cell purification systems
WO2012177647A2 (en) 2011-06-20 2012-12-27 Kerry Lane Mycotoxin diagnostics and methods thereof
US9677109B2 (en) 2013-03-15 2017-06-13 Accelerate Diagnostics, Inc. Rapid determination of microbial growth and antimicrobial susceptibility
US10253355B2 (en) 2015-03-30 2019-04-09 Accelerate Diagnostics, Inc. Instrument and system for rapid microorganism identification and antimicrobial agent susceptibility testing
AU2016243656A1 (en) 2015-03-30 2017-11-09 Accelerate Diagnostics, Inc. Instrument and system for rapid microorganism identification and antimicrobial agent susceptibility testing
CN110196219B (zh) * 2019-05-16 2022-06-03 扬州大学 一种基于流式细胞术检测鸡脾脏cd8+t细胞特异性杀伤作用的方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2716198B1 (fr) 1994-02-15 1996-04-19 Bio Merieux Facteur cytotoxique tel qu'associé à la sclérose en plaques, sa détection et sa quantification.
IT1278044B1 (it) 1995-03-09 1997-11-17 Salvatore Petraroli Metodologia per la realizzazione di un esame di laboratorio dell' integrita' in vitro delle cellule ematiche non fissate e/o

Also Published As

Publication number Publication date
EP0925504B1 (fr) 2001-03-14
EP0925504A1 (fr) 1999-06-30
WO1998011439A1 (fr) 1998-03-19
JP2001504686A (ja) 2001-04-10
ES2157569T3 (es) 2001-08-16
US6270953B1 (en) 2001-08-07
CA2266124A1 (fr) 1998-03-19
ATE199782T1 (de) 2001-03-15
DE69704279D1 (de) 2001-04-19
DE69704279T2 (de) 2001-10-31

Similar Documents

Publication Publication Date Title
Li et al. Responses of antioxidant systems in the hepatocytes of common carp (Cyprinus carpio L.) to the toxicity of microcystin-LR
DK0925504T3 (da) Fremgangsmåde til påvisning og/eller kvantitativ bestemmelse af en gliotoksisk faktor
Tamasloukht et al. Root factors induce mitochondrial-related gene expression and fungal respiration during the developmental switch from asymbiosis to presymbiosis in the arbuscular mycorrhizal fungus Gigaspora rosea
Hashimoto et al. Horizontal and vertical distribution of estrogenic activities in sediments and waters from Tokyo Bay, Japan
Esimbekova et al. Bioluminescent enzymatic rapid assay of water integral toxicity
Maalej et al. Temperature and growth-phase effects on Aeromonas hydrophila survival in natural seawater microcosms: role of protein synthesis and nucleic acid content on viable but temporarily nonculturable response
CN101198705B (zh) 通过在释放胞内酶前灭活胞外酶来鉴别样品中的细胞
Cavallo et al. Evaluation of oxidative damage and inhibition of DNA repair in an in vitro study of nickel exposure
AR000061A1 (es) Medio para detectar dentro de un lapso de 24 horasla presencía o ausencia de enterococos en una mue stra liquida cuya procedencia excluye aquellas tomadas de seres humanos y animales superiores.
WO2002084250A3 (en) Methods for mass spectrometry detection and quantification of specific target proteins in complex biological samples
Engelmann et al. Earthworm leukocytes kill HeLa, HEp-2, PC-12 and PA317 cells in vitro
Brandt et al. Microbial community-level toxicity testing of linear alkylbenzene sulfonates in aquatic microcosms
Brouwer Testing for chemical toxicity using bacteria: An undergraduate laboratory experiment
NO20050130L (no) Bakteriell testmetode ved glykatert merket binding
Arretxe et al. The effect of toxic discharges on ATP content in activated sludge
Garcés-Sanchez et al. Assessment of the viability of Cryptosporidium parvum oocysts with the induction ratio of hsp70 mRNA production in manure
Lezzoum-Atek et al. Influence of some parameters on the ability of Listeria monocytogenes, Listeria innocua, and Escherichia coli to form biofilms
Gaylarde Advances in detection of microbiologically induced corrosion
BR9612475A (pt) Método de determinação do estado hepático de uma pessoa incluíndo um beneficiário para transplante de figado
NZ505399A (en) A rapid method for the assessment of the inhibition and kill of anaerobic bacteria by toxic compounds
FR2816955B1 (fr) Substrat, substrat combines, milieu de culture et procede d'identification de l'espece listeria monocytogenes
Awerbuch et al. A numerical method to determine minimal inhibitory concentrations (MICs) of antibiotics directly from disc-diffusion susceptibility tests
WO2018212714A1 (en) Toxicity testing device and methods for making and using the same
BR0014455A (pt) Sequência de dna, proteìna, uso de uma sequência de dna, métodos para encontrar substâncias, para identificar substâncias com ação herbicida e para eliminar crescimento de plantas indesejadas, sistema de teste, e, inibidor
Larmour et al. Carbon dioxide fixation and conidiation in Fusarium culmorum grown in continuous culture